Redirecting targeted proteins for degradation can overcome acquired drug resistance
The true climate mitigation challenge is revealed by considering sustainability impacts
For times when wind and solar fall short, some utilities are turning to an old technology called pumped storage hydropower
Before he disappeared, Ettore Majorana made a strange prediction. Researchers are still hunting for the truth about him—and his namesake particles
Links between the complement and coagulation systems could lead to Long Covid therapies
To zoom in farther, Event Horizon Telescope wants to add more radio dishes to its network—and go to space
The latest star maps are rewriting the story of our Milky Way, revealing a much more tumultuous history than astronomers suspected
To understand why the universe is made of matter and not antimatter, physicists are looking for a tiny signal in the electron
Special assemblages of minuscule fossils bring dinosaur ecosystems to life
Greenhouse gases, El Niño, and cleaner air fueled record heat in 2023
Peeled-apart Indian Plate could be affecting earthquake hazards
Specific brain pathways can lower or raise the willingness of monkeys to take risks
Rethink of familiar object may boost odds that its name, offensive to some, will be changed
A ghostly quasiparticle rooted in a century-old Italian mystery could unlock quantum computing’s potential—if only it could be pinned down
Preference for cash and privacy fears deterred bitcoin adoption in El Salvador.
Encapsulated aerogel fibers offer thermal insulation, breathability, and strength
Blockbuster weight loss drugs show promise for a wider range of health benefits
Obesity plays out as a private struggle and a public health crisis. In the United States, about 70% of adults are affected by excess weight, and in Europe that number is more than half. The stigma against fat can be crushing; its risks, life-threatening. Defined as a body mass index of at least 30, obesity is thought to power type 2 diabetes, heart disease, arthritis, fatty liver disease, and certain cancers.
Medicine has had little to offer the tens of millions of people worldwide with Alzheimer’s disease, and the few approved treatments have only targeted symptoms. But in January, U.S. regulators greenlit the first drug that clearly, if modestly, slows cognitive decline by tackling the disease’s underlying biology; a second, related treatment is close behind. Neither comes close to a cure, and both have serious risks, but they offer new hope to patients and families.
New research is revealing surprising complexity in the minds of goats, pigs, and other livestock
Biomedical microrobots could overcome current challenges in targeted therapies
Sustainable management approaches are needed to protect coastal environments
Boomers Daily 